Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524238 | NSE Symbol : | ISIN : INE659F01014 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
13-Feb-2025	18-Feb-2025	Stock Split	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/02/2025 inter alia to consider and approve proposal for sub- division/split of the equity shares of the Company in such manner as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities as may be required Outcome of the Board Meeting held on Tuesday 18th February, 2025 1. Approved Stock-split/sub-division of each equity share of the Company, having face value of Rs.10/- each, into 1 (One) equity share of face value Re. 1/- each, subject to approval of the shareholders of the Company and other statutory/regulatory authorities, as may be required. In this respect, the record shall be decided by the Board separately which shall be intimated to Exchange in the due course. 2. Approved substitution / alteration in the Main Object Clauses of the Memorandum of Association of the Company subject to approval of the shareholders of the Company in the ensuing Annual General Meeting/Extra Ordinary General Meeting of the Company. 3. Approved the proposed change in name of the Company from Gujarat Inject (Kerala) Limited to Shrikara Enterprise Limited' or any other name as may be available and approved by Ministry of Corporate Affairs and consequential alteration in Memorandum of Association and Articles of Association of the Company to give effect to the change of name of the Company, subject to the approval of shareholders of the Company by way of special resolution and other concerned authorities (As Per BSE Announcement Dated on 18.02.2025)
01-Feb-2025	05-Feb-2025	Stock Split	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve proposal for sub- division/split of the equity shares of the Company in such manner as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities as may be required Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company, at its meeting held today i.e., Wednesday, 5th February, 2025, could not come to conclusion on the subject matter of Stock Split/sub-division of the equity shares of the company due to some technical and unavoidable circumstances. (As Per Bse Announcement Dated on 05.02.2025)
18-Jan-2025	23-Jan-2025	Quarterly Results	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve & take on record the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and any other items as may be decided by the Board of Directors. In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on January 23, 2025, at the Registered Office of the Company which was commenced at 05:00 P.M. and concluded at 05:20 P.M., have, apart from other businesses, 1) Considered, approved and taken on record the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report (Unmodified Opinion) In this regards, we are hereby submitting the followings: 1. Unaudited Financial Results for the quarter and nine months ended on December 31, 2024; 2. Limited review report; Kindly take the same on your record and oblige us Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report (Unmodified Opinion) (As per BSE Announcement Dated on 23/01/2025)
07-Oct-2024	22-Oct-2024	Quarterly Results	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of our Company is scheduled to be held on Tuesday October 22 2024 at the registered office of the Company situated at Shop No. 15 K-Tower Haveli Resi-Cum Plaza Behind Air Force Station Makarpura Vadodara - 390014 Gujarat India to consider approve & take on record the Unaudited Standalone Financial Results of the Company for the quarter and half year ended on September 30 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and any other items as may be decided by the Board of Directors. In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on October 22, 2024, at the Registered Office of the Company which was commenced at 04:00 P.M. and concluded at 04:40 P.M., have, apart from other businesses, 1) Considered, approved and taken on record the Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2024 along with Limited Review Report (Unmodified Opinion) In this regards, we are hereby submitting the followings: 1. Unaudited Financial Results for the quarter and half year ended on September 30, 2024; 2. Limited review report; Read less.. Unaudited Financial Result of the Company for the quarter and half year ended on September 30, 2024 along with Limited Review Report (Unmodified Opinion) (As Per BSE Announcement Dated on 22.10.2024)
02-Aug-2024	10-Aug-2024	Quarterly Results	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2024 inter alia to consider and approve take on record the Unaudited Standalone Financial Results of the Company for the quarter ended on June 30 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and any other items as may be decided by the Board of Directors. we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on August 10, 2024, at the Registered Office of the Company which was commenced at 03:15 P.M. and concluded at 03:40 P.M (As Per BSE Announcement Dated on: 10/08/2024)
10-Jun-2024	10-Jun-2024	Change in Other Executives	Appointed Ms. Manmeetkaur Harshdeepsingh Bhatia as a Company Secretary and Compliance Officer of the Company with effect from June 10, 2024.
15-May-2024	15-May-2024	Others	The Board of Directors of the Company, at its meeting held today i.e. on May 15, 2024, considered and approved the request received from the following entity for re-classification from 'PROMOTER' category to 'PUBLIC' category of the Company based on confirmations received from the said entity in line with Regulation 31A of the SEBI Listing Regulations, subject to approval of the Stock Exchanges and/or other approval, if any, as may be required: Sr. No. Name Category No of Equity Share held Percentage of Shareholding 1. Kerala State Industrial Development Corporation Limited Promoter 200 0.00% In accordance with Regulation 31A of the SEBI Listing Regulations, please find enclosed the extract of the Minutes of the resolution passed by the Board of Directors of the Company in this regard. Kindly take the same on your record and oblige us. Disclosure Under Regulation 30 read with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Submission of Application for Re-Classification from ''Promoter'' Category to ''Public'' Category (As Per BSE Announcement Dated on 17.05.2024)
02-May-2024	09-May-2024	Accounts	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2024 inter alia to consider and approve & take on record the Audited Financial Results of the Company for the quarter and year ended on March 31 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and any other items as may be decided by the Board of Directors. we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on May 9, 2024, at the Registered Office of the Company which was commenced at 04:30 P.M. and concluded at 05:00 P.M., have, apart from other businesses, considered, approved and taken on record the Audited Financial Results of the Company for the quarter and year ended on March 31, 2024 along with Auditor's Reports (Unmodified Opinion) and Declaration for the Auditor's Reports with Unmodified Report. In this regards, we are hereby submitting the followings: 1.Audited Financial Results for the quarter and year ended on March 31, 2024; 2. Statement of Assets and Liabilities; 3.Cash Flow Statements; 4.Audit Reports' (unmodified opinion) on the Audited Financial Results; 5.Declaration by the Company (for audit reports with unmodified opinion); 6.Statement of Utilization of issue proceeds of Preferential Issue. Kindly take the same on your record and oblige us. Results - Audited Financials Results of the Company for the quarter and year ended on March 31, 2024 along with Auditor''s Report (Unmodified Opinion) and Declaration for the Auditor''s reports with Unmodified Report (As Per BSE Announcement Dated on 09/05/2024)
03-May-2024	03-May-2024	Change in Auditors	In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on May 3, 2024, at the Administrative Office of the Company which was commenced at 03:00 P.M. and concluded at 03:15 P.M., has, inter alia, apart from other business, considered and approved; 1. Re-appointed Mr. Anand Lavingia, Practicing Company Secretary as Secretarial Auditor of the Company for obtaining the Secretarial Audit Report for the financial year 2023-24. (brief Profile of Mr. Anand Lavingia is attached herewith as Annexure 1); 2. Re-appointed M/s. R B Gohil & Co. as Internal Auditor of the Company for the financial year 2024-25. (brief Profile of M/s. R B Gohil & Co. is attached herewith as Annexure 2). Kindly take the same on your record and oblige us. Read less..
05-Feb-2024	13-Feb-2024	Quarterly Results	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve & take on record the Unaudited Financial Result for the quarter ended on December 31 2023 as per Regulation 33 of the Listing Regulation and any other items as may be decided by the Board of Directors. In this connection and in continuation of our intimation regarding Closure of Trading Window for the Insiders of the Company vide letter dated December 30 2023 the trading window for dealing in the securities of the Company is already closed for the Insiders of the Company since Monday January 1 2024. Kindly take the same on your record and oblige us. In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on February 13, 2024, at the Administrative Office of the Company which was commenced at 04:30 P.M. and concluded at 05:00 P.M. have transacted following businesses: 1) Considered, approved and took on record the Unaudited Financial Results for the quarter and nine months ended on December 31, 2023 along with the limited review report. In this regards, we are submitting the followings: a) Unaudited Financial Results for the quarter and nine months ended on December 31, 2023; b) Limited Review Report; There is no other business to be transacted apart from this. Kindly take the same on your record and oblige us. Outcome of Board Meeting held today i.e. on February 13, 2024 and standalone unaudited financial results for the quarter and nine months ended December 31, 2023 (As per BSE Announcement Dated on 13/02/2024)
08-Feb-2024	08-Feb-2024	Preferential Issue	Allotment of warrants of Face value of Rs. 10.00 on preferential issue basis
13-Dec-2023	16-Dec-2023	Preferential Issue	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/12/2023 inter alia to consider and approve the issuance of securities of Preferential Basis and any other items of businesses as the Board may think fit. In this connection in accordance with BSE Circular no. LIST /COMP/01/2019 20 dated April 2 2019 - Clarification regarding trading restriction period and the Securities and Exchange Board of India (Prohibition of Insider Trading) (Second Amendment) Regulations 2019 the trading window for dealing in Equity Shares of the Company by the Insiders covered under Companys Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities has been closed from December 13 2023 and shall remain closed till 48 hours after the declaration and publication of Outcome of Board Meeting to be held on Saturday December 16 2023. Kindly take the same on your record and oblige us. 1. Proposed approval of shareholders for increase in the Authorized Share Capital of the Company 2. Approved issue of up to 10000000 warrants each convertible into or exchangeable for, 1 (one) fully paidup equity share of the Company of face value of Rs. 10/- each to the proposed allottees, on a preferential basis ('Preferential Issue') 3. Approved alteration in Memorandum of Association of the Company in line with the Companies Act, 2013 and addition of Object related to Agriculture Products 4. Approved adoption of new set of Articles of Association of the Company in line with the Companies Act, 2013; 5. Appointed National Securities Depository Limited (NSDL) as Remote E-Voting Agency for resolutions proposed to be passed at Extra Ordinary General Meeting. (As Per BSE Announcement dated on 16.12.2023)
17-Nov-2023	22-Nov-2023	Conversion	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/11/2023 inter alia to consider and approve 1) acceptance of unsecured Loans with an option of conversion into equity shares of Gujarat Inject Kerala Limited subject to obtaining requisite approval of the shareholders of the Company; 2) an increasing borrowing limits in excess of the limit specified under section 180(1)(c) of Companies Act 2013 subject to obtaining requisite approval of the shareholders of the Company and 3) Any other items of business The trading window for dealing in Equity shares of the Company by the Insiders covered under Company''s code of Internal procedures and conduct for prevention of Insider trading in securities has already been closed 17/11/2023 and shall remain closed till 48 hours after declaration and publication of outcome of Board meeting to be held on 22/11/2023 (As Per BSE Announcement Dated on 18/11/2023) In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on Wednesday, November 22, 2023 at the Administrative Office of the Company which was commenced at 03:30 P.M. and concluded at 04:15 P.M. have inter alia: 1) To took note of the withdrawal of proposal for raising funds by way of acceptance of unsecured Loans with an option of conversion into equity shares of Gujarat Inject Kerala Limited, subject to obtaining requisite approval of the shareholders of the Company. There is no other business to be transacted apart from this. (As Per BSE Announcement Dated on 22/11/2023)
26-Oct-2023	06-Nov-2023	Quarterly Results	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve 1) To consider approve & take on record the Unaudited Financial Result for the quarter ended on September 30 2023 as per Regulation 33 of the Listing Regulation 2) To consider the proposal for raising funds by way of issue of one or more instruments including equity shares convertible securities of any description or warrants or debt securities through preferential issue private placements rights issue or any other methods or combination thereof as may be permitted under applicable laws subject to such regulatory/statutory approvals as may be required including the approval of the shareholders of the Company and 3) Any other items as may be decided by the Board of Directors GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 ,inter alia, to consider and approve 1) To consider, approve & take on record the Unaudited Financial Result for the quarter ended on September 30, 2023 as per Regulation 33 of the Listing Regulation, 2) To consider the proposal for raising funds by way of issue of one or more instruments including equity shares, convertible securities of any description or warrants or debt securities, through preferential issue, private placements, rights issue or any other methods or combination thereof as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required, including the approval of the shareholders of the Company, and 3) Any other items as may be decided by the Board of Directors (As Per BSE Announcement dated on 26.10.2023) GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 ,inter alia, to consider and approve To consider, approve & take on record the Unaudited Financial Result for the quarter ended on September 30, 2023 as per Regulation 33 of the Listing Regulation, 2) To consider the proposal for raising funds by way of issue of one or more instruments including equity shares, convertible securities of any description or warrants or debt securities, through preferential issue, private placements, rights issue or any other methods or combination thereof as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required, including the approval of the shareholders of the Company, and 3) Any other items as may be decided by the Board of Directors. The closure of trading window as intimated to stock exchange earlier will continue till 48 hours from the conclusion of Board Meeting. (As Per BSE Announcement Dated on 03/11/2023) Quarterly Result for Quarter ended on September 30, 2023. to took note of the withdrawal of proposal for raising funds by way of issue of one or more instruments including equity shares, convertible securities of any description or warrants or debt securities, through preferential issue, private placements, rights issue or any other methods or combination thereof (As Per BSE Announcement dated on 06.11.2023)
07-Sep-2023	07-Sep-2023	AGM	we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on thursday, September 07, 2023, have: Approved Draft Directors'' Report for the financial year 2022-23 along with its Annexures and other reports to be included in the Annual Report 2022-23;2.Decided to call the 32nd Annual General Meeting of the Company on Saturday, September 30, 2023 at 01:00 P.M. IST through Video Conference (VC) .3.Appointed National Securities Depository Limited (NSDL) as Remote E-Voting Agency for resolutions proposed to be passed at Annual General Meeting.4.Appointed Mr. Anand Sureshbhai Lavingia, Company Secretary in Practice (ACS: 26458 COP: 11410) as Scrutinizer.

1 2 3

LOGIN HERE

Gujarat Inject (Kerala) Ltd

Board Meeting